The Evolution of Diagnosis and Management of Pediatric Biliary Tract Rhabdomyosarcoma
Journal:
Current Pediatric Reviews
Volume:
12
Page:
190-198
Author(s):
Alpin D. Malkan and Israel Fernandez-Pineda
Refractory Chronic Lymphocytic Leukemia: A Therapeutic Challenge
Journal:
Current Cancer Drug Targets
Volume:
16
Page:
701-709
Author(s):
Lukas Smolej
Functional and Clinical Significance of the Integrin Alpha Chain CD49d Expression in Chronic Lymphocytic Leukemia
Journal:
Current Cancer Drug Targets
Volume:
16
Page:
659-668
Author(s):
Michele Dal Bo, Erika Tissino, Dania Benedetti, Chiara Caldana, Riccardo Bomben, Giovanni Del Poeta, Gianluca Gaidano, Francesca Maria Rossi, Pietro Bulian, Antonella Zucchetto and Valter Gattei
Deregulation of Apoptosis - Is it Still an Important Issue in Pathogenesis of Chronic Lymphocytic Leukemia?
Journal:
Current Cancer Drug Targets
Volume:
16
Page:
652-658
Author(s):
Monika Podhorecka, Arkadiusz Macheta, Maria Bozko, Andrzej Bozko, Nisar P. Malek and Przemyslaw Bozko
QT Prolongation and Anticancer Drugs: Is it a Cardiologist’s Worry? The Oncologist’s Point of View
Journal:
Reviews on Recent Clinical Trials
Volume:
11
Page:
260-265
Author(s):
Francesca Aroldi, Tiziana Prochilo, Elena Bonini and Alberto Zaniboni
Recent Advances in Heterocyclic Tubulin Inhibitors Targeting the Colchicine Binding Site
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
16
Page:
1325-1338
Author(s):
Xiaoxin Wu, Qinghui Wang and Wei Li
Endocannabinoid System: A Promising Therapeutic Target for the Treatment of Haematological Malignancies?
Journal:
Current Medicinal Chemistry
Volume:
23
Page:
2350-2362
Author(s):
Constantinos Giaginis, Eleftheria Lakiotaki, Penelope Korkolopoulou, Konstantinos Konstantopoulos, Efstratios Patsouris and Stamatios Theocharis
Targeting Hsp90 in Non-Cancerous Maladies
Journal:
Current Topics in Medicinal Chemistry
Volume:
16
Page:
2792-2804
Author(s):
Mark R. Woodford, Diana M. Dunn, Joseph G. Ciciarelli, Kristin Beebe, Len Neckers and Mehdi Mollapour
Historical Spice as a Future Drug: Therapeutic Potential of Piperlongumine
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
4151-4159
Author(s):
Sahdeo Prasad and Amit K. Tyagi
Persistent GP130/STAT3 Signaling Contributes to the Resistance of Doxorubicin, Cisplatin, and MEK Inhibitor in Human Rhabdomyosarcoma Cells
Journal:
Current Cancer Drug Targets
Volume:
16
Page:
631-638
Author(s):
Xiaojuan Wu, Hui Xiao, Ruoning Wang, Lingling Liu, Chenglong Li and Jiayuh Lin